Folic Acid Supplementation in Dementia: A Preliminary Report

Journal of Geriatric Psychiatry and Neurology

Volumn 16, Issue 3, 2003, Pages 156-159

  Sommer, Barbara R ^a   Hoff, Anne L ^c   Costa, Martin ^b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NONE

Author keywords

Cognition; Folic acid; Psychological testing

Indexed keywords

FOLIC ACID; HOMOCYSTEINE; PLACEBO;

AGED; ALZHEIMER DISEASE; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMENTIA; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG MEGADOSE; DRUG SCREENING; DRUG TOLERABILITY; EVALUATION; FEMALE; FOLIC ACID BLOOD LEVEL; FOLLOW UP; HIGH RISK PATIENT; HUMAN; MALE; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; RISK ASSESSMENT; SCORING SYSTEM; TASK PERFORMANCE; VITAMIN SUPPLEMENTATION;

AGED; ALZHEIMER DISEASE; COGNITION DISORDERS; FEMALE; FOLIC ACID; HOMOCYSTEINE; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; PREVALENCE; RISK FACTORS;

EID: 0242680428     PISSN: 08919887     EISSN: None     Source Type: Journal    
DOI: 10.1177/0891988703256052     Document Type: Article

References (19)

1. Sommer, BR, Wolkowitz OM, RBC folic acid levels and cognitive performance in elderly patients: a preliminary report. Biol Psychiatry 1988; 24:352-354.
2. Seshadri S, Beiser A, Selhub J, et al. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med 2002; 346:476-483.
3. Clark R, Smith D, Jobst KA, et al. Folate, vitamin B12 and serum total homocysteine levels in confirmed Alzheimer's disease. Arch Neurol 1998; 55:1449-1455.
4. Selhub J, Jacques PF, Wilson PW, et al. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA 1993; 270:2693-2698.
5. Yukawa M, Naka H, Murata Y, et al. Folic acid-responsive neurological diseases in Japan. J Nutr Sci Vitaminol 2001; 47:181-187.
6. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state," a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12:189-198.
7. Nilsson K, Gustafson L, Hultberg B. Improvement of cognitive functions after cobalamin/folate supplementation in elderly patients with dementia and elevated plasma homocysteine. Int J Geriatr Psychiatry 2001; 16:609-614.
8. Hunter R. Toxicity of folic acid given in pharmacological doses to healthy volunteers. Lancet 1970; 1:61-62.
9. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 3rd ed., rev. Washington DC: American Psychiatric Press, 1987.
10. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23:56-62.
11. Overall JE, Gorham DR. The brief psychiatric rating scale. Psychol Rep 1962; 10:799-812.
12. Lezak MD. Neuropsychological assessment. 3rd ed. New York: Oxford University Press, 1995.
13. Wechsler D. Wechsler Adult Intelligence Scale-Revised manual. New York: The Psychological Corporation, Harcourt, Brace, and Jovanovich, 1982.
14. Kaplan E, Goodglass H, Weintraub S. The Boston Naming Test. Philadelphia, Pa: Lea and Febiger, 1983.
15. Benton AL, Hamsher K, Sivan AB. Multilingual aphasia examination. 3rd ed. Iowa City, Ia: AJA Associates, 1994.
16. Wechsler D, Stone CP. Wechsler Memory Scale manual. New York: The Psychological Corporation, Harcourt, Brace and Jovanovich, 1955.
17. Benton AL. Revised Visual Retention Test. 5th ed. New York: The Psychological Corporation, Harcourt, Brace, and Jovanovich, 1955.
18. Reitan RM. Trail Making Test: Manual for administration and scoring. Tucson, Az: Reitan Neuropsychological Laboratory, 1992.
19. Reitan RM, Davidson, LA. Clinical neuropsychology: Current status and applications. New York: Hemisphere, 1974.